London-listed shares of Glanbia surge on  outlook upgrade

Glanbia

13/08/2025 08:30

** London-listed shares of nutrition supplement maker Glanbia GL9.L GL9.I up 11% at 13.6 cents, highest since February

** Co now expects FY group adjusted EPS in range of $1.30 to $1.33 (previously $1.24 to $1.30)

** Posts H1 revenue up 6.1% Y/Y

** Also, appoints Paul Duffy as chair designate

** Including session's moves, GL9 up ~4% YTD

(Reporting by Nithyashree R B in Bengaluru)

((NithyashreeRB@thomsonreuters.com))